Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
6.72
-0.04 (-0.59%)
Mar 11, 2026, 3:04 PM CST
SHE:000153 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,141 | 2,849 | 3,111 | 4,503 | 3,739 | 2,747 | Upgrade
|
| Market Cap Growth | 9.90% | -8.42% | -30.92% | 20.43% | 36.14% | 33.13% | Upgrade
|
| Enterprise Value | 3,876 | 3,512 | 3,661 | 4,669 | 4,077 | 3,181 | Upgrade
|
| Last Close Price | 6.76 | 6.03 | 6.46 | 9.25 | 8.07 | 5.93 | Upgrade
|
| PE Ratio | 27.60 | 17.71 | 19.53 | 29.16 | 30.41 | 26.48 | Upgrade
|
| PS Ratio | 0.76 | 0.67 | 0.73 | 1.13 | 1.02 | 0.83 | Upgrade
|
| PB Ratio | 1.48 | 1.39 | 1.62 | 2.57 | 2.11 | 1.90 | Upgrade
|
| P/TBV Ratio | 1.69 | 1.61 | 1.85 | 2.91 | 2.38 | 2.21 | Upgrade
|
| P/FCF Ratio | - | - | 30.31 | 12.57 | 35.69 | 26.93 | Upgrade
|
| P/OCF Ratio | 21.43 | 22.57 | 12.21 | 10.24 | 14.13 | 9.38 | Upgrade
|
| EV/Sales Ratio | 0.93 | 0.82 | 0.86 | 1.17 | 1.12 | 0.96 | Upgrade
|
| EV/EBITDA Ratio | 19.93 | 12.90 | 12.43 | 17.73 | 16.87 | 16.44 | Upgrade
|
| EV/EBIT Ratio | 57.48 | 20.43 | 18.91 | 27.49 | 26.13 | 25.93 | Upgrade
|
| EV/FCF Ratio | -65.96 | - | 35.67 | 13.03 | 38.91 | 31.19 | Upgrade
|
| Debt / Equity Ratio | 0.45 | 0.48 | 0.36 | 0.42 | 0.35 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 4.89 | 3.29 | 2.15 | 2.53 | 2.31 | 3.15 | Upgrade
|
| Debt / FCF Ratio | - | - | 6.70 | 2.06 | 5.97 | 5.98 | Upgrade
|
| Net Debt / Equity Ratio | 0.33 | 0.36 | 0.19 | 0.17 | 0.19 | 0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | 4.24 | 2.70 | 1.25 | 1.15 | 1.42 | 1.69 | Upgrade
|
| Net Debt / FCF Ratio | -12.08 | -41.27 | 3.58 | 0.85 | 3.27 | 3.21 | Upgrade
|
| Asset Turnover | 0.86 | 0.94 | 0.97 | 0.94 | 0.95 | 0.92 | Upgrade
|
| Inventory Turnover | 5.89 | 5.76 | 5.00 | 4.26 | 4.35 | 4.29 | Upgrade
|
| Quick Ratio | 0.62 | 0.59 | 0.60 | 0.53 | 0.57 | 0.53 | Upgrade
|
| Current Ratio | 0.91 | 0.90 | 0.95 | 0.89 | 0.96 | 0.84 | Upgrade
|
| Return on Equity (ROE) | 5.34% | 7.95% | 8.56% | 8.56% | 7.32% | 7.36% | Upgrade
|
| Return on Assets (ROA) | 0.88% | 2.36% | 2.73% | 2.49% | 2.54% | 2.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.89% | 5.13% | 6.52% | 6.07% | 5.92% | 5.43% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.50% | 6.80% | 8.10% | 8.00% | 7.40% | 7.80% | Upgrade
|
| Earnings Yield | 3.62% | 5.64% | 5.12% | 3.43% | 3.29% | 3.78% | Upgrade
|
| FCF Yield | -1.87% | -0.62% | 3.30% | 7.95% | 2.80% | 3.71% | Upgrade
|
| Dividend Yield | 1.50% | 1.66% | 1.66% | 0.77% | 0.88% | - | Upgrade
|
| Payout Ratio | 63.89% | 44.87% | 40.29% | 37.22% | 21.37% | 37.02% | Upgrade
|
| Buyback Yield / Dilution | 0.07% | 0.05% | -4.71% | -1.59% | -0.03% | 0.17% | Upgrade
|
| Total Shareholder Return | 1.57% | 1.71% | -3.05% | -0.82% | 0.85% | 0.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.